TRICARE保险儿童复发性急性中耳炎:鼓膜置管与药物管理比较
本研究为回顾性匹配队列研究,基于TRICARE索赔数据库2006至2010年数据,比较≤5岁复发性急性中耳炎患儿接受鼓膜置管(TT)与药物管理的感染次数和医疗利用。1年随访时TT组感染次数和口服抗生素处方更少,但就诊次数更多;2年随访时TT获益不再显现。
要点
- TT组1年感染次数1.96 vs 药物组2.18(P < .001),口服抗生素处方1.52 vs 1.67(P < .001)。
- TT组1年 primary care 就诊4.36 vs 4.06(P < .0001),耳鼻咽喉科就诊1.21 vs 0.44(P < .0001)。
- 2年随访时TT获益不再显现。
核心结论
- TT placement for RAOM is associated with fewer infections and oral antibiotic prescriptions in the first year after surgery but more doctor visits.
- Benefits of TT placement do not appear to extend through the second year.
研究设计与样本
- 回顾性匹配队列研究,使用TRICARE索赔数据库2006至2010年数据。
- 匹配≤5岁诊断为RAOM并接受TT置入的受益人与药物管理受益人,采用1:1粗化精确匹配,匹配变量包括年龄、性别、种族、担保人级别和地区。
- 使用多变量负二项回归比较1年和2年时的感染次数和医疗利用,并调整治疗前RAOM感染率、TT置入或TT候选资格确立的季节以及合并症。
主要发现
- 1年随访时共识别6659对匹配,TT组感染次数1.96 vs 药物管理组2.18(P < .001),口服抗生素处方1.52 vs 1.67(P < .001)。
- TT组初级保健医生就诊次数4.36 vs 药物管理组4.06(P < .0001),耳鼻咽喉科医生就诊次数1.21 vs 0.44(P < .0001)。
- 2年随访时,TT置入的获益不再显现。
临床怎么用
- 对于TRICARE保险的≤5岁RAOM患儿,TT置入可能与第一年感染次数和口服抗生素处方减少相关,但医生就诊次数增加。
- TT置入的获益似乎不延伸至第二年。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective To compare number of infections and health care utilization in children insured by TRICARE with recurrent acute otitis media (RAOM) managed surgically with tympanostomy tube (TT) placement compared with those managed medically. Study Design Retrospective matched cohort study. Setting TRICARE claims database from 2006 to 2010. Subjects and Methods We matched TRICARE beneficiaries ≤5 years of age diagnosed with RAOM who underwent TT placement with those managed medically using 1:1 coarsened-exact matching on age, sex, race, sponsor rank, and region. We used multivariable negative binomial regression to compare number of infections and health care utilization at 1 and 2 years. Outcomes were adjusted for rate of infection before treatment for RAOM, season of either TT placement or establishment of candidacy for TT placement, and comorbidities. Results Among 6659 pairs identified at 1-year follow-up, the TT group had fewer infections (1.96 vs 2.18, P < .001) and oral antibiotic prescriptions (1.52 vs 1.67, P < .001) but more visits to primary care physicians (4.36 vs 4.06, P < .0001) and otolaryngologists (1.21 vs 0.44, P < .0001) compared with the medically managed group. At 2-year follow-up, the benefits of TT placement were no longer seen. Conclusion TT placement for RAOM is associated with fewer infections and oral antibiotic prescriptions in the first year after surgery but more doctor visits. Benefits of TT placement do not appear to extend through the second year. Future research should investigate costs associated with TT placement vs medical management, as well as real-time health care utilization with impact on patient symptoms and quality of life.
引用
- Raol N, Sharma M, Boss EF, et al. Tympanostomy Tube Placement vs Medical Management for Recurrent Acute Otitis Media in TRICARE-Insured Children. Otolaryngol Head Neck Surg. 2017. PMID: 28535362. doi:10.1177/0194599817707718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。